Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - daunorubicin hydrochloride - powder for concentrate for solution for infusion - 20 milligram(s) - anthracyclines and related substances; daunorubicin

Kanada - inglise - Health Canada

searchlight pharma inc - daunorubicin (daunorubicin hydrochloride) - powder for solution - 20mg - daunorubicin (daunorubicin hydrochloride) 20mg - antineoplastic agents

Malta - inglise - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - daunorubicin - powder for concentrate for solution for infusion - daunorubicin 20 mg - antineoplastic agents

Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - daunorubicin hydrochloride 21.4mg equivalent to 20 mg daunorubicin - powder for injection - 20 mg - active: daunorubicin hydrochloride 21.4mg equivalent to 20 mg daunorubicin excipient: mannitol

Belgia - inglise - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sanofi belgium sa-nv - daunorubicin hydrochloride 21,4 mg - eq. daunorubicin 20 mg - powder and solvent for solution for infusion - 20 mg - daunorubicin hydrochloride 21.4 mg - daunorubicin

Malta - inglise - Medicines Authority

jv healthcare limited navi buidlings, pantar road, lija, lja 2021, malta - powder and solvent for solution for injection - daunorubicin 20 mg - antineoplastic agents

Kanada - inglise - Health Canada

generic medical partners inc - daunorubicin (daunorubicin hydrochloride) - solution - 20mg - daunorubicin (daunorubicin hydrochloride) 20mg - antineoplastic agents

Kanada - inglise - Health Canada

generic medical partners inc - daunorubicin (daunorubicin hydrochloride) - solution - 50mg - daunorubicin (daunorubicin hydrochloride) 50mg - antineoplastic agents

Kanada - inglise - Health Canada

hikma canada limited - daunorubicin (daunorubicin hydrochloride) - solution - 20mg - daunorubicin (daunorubicin hydrochloride) 20mg

Euroopa Liit - inglise - EMA (European Medicines Agency)

merck sharp & dohme b.v. - daptomycin - gram-positive bacterial infections; bacteremia; soft tissue infections; endocarditis, bacterial - antibacterials for systemic use, - cubicin is indicated for the treatment of the following infections.adult and paediatric (1 to 17 years of age) patients with complicated skin and soft-tissue infections (cssti).adult patients with right-sided infective endocarditis (rie) due to staphylococcus aureus.it is recommended that the decision to use daptomycin should take into account the antibacterial susceptibility of the organism and should be based on expert advice.adult and paediatric (1 to 17 years of age) patients with staphylococcus aureus bacteraemia (sab). in adults, use in bacteraemia should be associated with rie or with cssti, while in paediatric patients, use in bacteraemia should be associated with cssti.daptomycin is active against gram positive bacteria only. in mixed infections where gram negative and/or certain types of anaerobic bacteria are suspected, cubicin should be co-administered with appropriate antibacterial agent(s). consideration should be given to official guidance on the appropriate use of antibacterial agents.